The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs.
Haematologica
; 105(10): 2420-2431, 2020 10 01.
Article
in En
| MEDLINE
| ID: mdl-33054082
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Protein Kinase Inhibitors
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2020
Document type:
Article